| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.0081 | 0.8 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.008 | 0.8 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.8 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |